173 related articles for article (PubMed ID: 29269695)
21. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
[TBL] [Abstract][Full Text] [Related]
22. Use of infliximab and other biologics in Behçet disease.
Li J; Fernando S; Herkes G
Intern Med J; 2014 Jan; 44(1):96-100. PubMed ID: 24450526
[TBL] [Abstract][Full Text] [Related]
23. [Central nervous system involvement in Behçet's disease].
Hirohata S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1147-9. PubMed ID: 12235822
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome.
Akman-Demir G; Tüzün E; Içöz S; Yeşilot N; Yentür SP; Kürtüncü M; Mutlu M; Saruhan-Direskeneli G
Cytokine; 2008 Dec; 44(3):373-6. PubMed ID: 19010690
[TBL] [Abstract][Full Text] [Related]
25. Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation.
Mitsui Y; Mitsui M; Urakami R; Kihara M; Takahashi M; Kusunoki S
Intern Med; 2005 Feb; 44(2):149-52. PubMed ID: 15750277
[TBL] [Abstract][Full Text] [Related]
26. [The analysis of cytokines in cerebrospinal fluid (CSF) in two cases of non-herpetic acute limbic encephalitis (NHALE)].
Takahashi T; Kamei S; Miki K; Ogawa K; Mizutani T
Rinsho Shinkeigaku; 2003 Apr; 43(4):162-9. PubMed ID: 12884825
[TBL] [Abstract][Full Text] [Related]
27. [A case of Behçet disease developing recurrent ischemic stroke with fever and scrotal ulcers].
Koike Y; Sakai N; Umeda Y; Umeda M; Oyake M; Fujita N
Rinsho Shinkeigaku; 2015; 55(6):428-31. PubMed ID: 26103818
[TBL] [Abstract][Full Text] [Related]
28. [A case of neuro-Behçet disease presenting with a longitudinal spinal cord lesion without pain].
Sakuta K; Sengoku R; Morita M; Matsusima S; Mochio S; Iguchi Y
Rinsho Shinkeigaku; 2014; 54(1):16-21. PubMed ID: 24429643
[TBL] [Abstract][Full Text] [Related]
29. Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.
Hirohata S; Kikuchi H
Intern Med; 2012; 51(24):3359-65. PubMed ID: 23257520
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.
Hirohata S; Isshi K; Oguchi H; Ohse T; Haraoka H; Takeuchi A; Hashimoto T
Clin Immunol Immunopathol; 1997 Jan; 82(1):12-7. PubMed ID: 9000037
[TBL] [Abstract][Full Text] [Related]
31. Refractory neuro-Behçet treated by tocilizumab: a case report.
Urbaniak P; Hasler P; Kretzschmar S
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S73-5. PubMed ID: 23020826
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
[TBL] [Abstract][Full Text] [Related]
33. [Enuresis as the initial manifestation of neuro-Behçet's disease. A case report].
Narusako T; Ueyama H; Fujimoto S; Oono H; Kumamoto T; Tsuda T
Rinsho Shinkeigaku; 2001; 41(4-5):191-4. PubMed ID: 11676161
[TBL] [Abstract][Full Text] [Related]
34. [Case of neuro-Behçet disease with HLA-B54, Cw1, which is difficult in clinical diagnosis from neuro-Sweet disease].
Sato M; Yoneda M; Kumakiri M; Kuriyama M
Rinsho Shinkeigaku; 2009 Aug; 49(8):479-82. PubMed ID: 19827597
[TBL] [Abstract][Full Text] [Related]
35. [Magnetic resonance imaging of brainstem lesions in a case of neuro-Behçet disease].
Nomura E; Izumi Y; Yamashita H; Kamei H; Nakamura S; Wakabayashi C; Yamaguchi S; Kajikawa H; Shohge K
No To Shinkei; 1997 Mar; 49(3):273-6. PubMed ID: 9125733
[TBL] [Abstract][Full Text] [Related]
36. Neuro-Behçet: differential diagnosis of recurrent meningitis.
Fonseca Cardoso A; Rocha-Filho PA; Melo Correa-Lima AR
Rev Med Chil; 2013 Jan; 141(1):114-8. PubMed ID: 23732423
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
J Neurol Sci; 2015 Feb; 349(1-2):143-8. PubMed ID: 25601769
[TBL] [Abstract][Full Text] [Related]
38. [Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease].
Suda H
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):13-22. PubMed ID: 11185687
[TBL] [Abstract][Full Text] [Related]
39. Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.
Hibi T; Hirohata S; Kikuchi H; Tateishi U; Sato N; Ozaki K; Kondo K; Ishigatsubo Y
Medicine (Baltimore); 2016 Jun; 95(24):e3863. PubMed ID: 27310969
[TBL] [Abstract][Full Text] [Related]
40. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
